Related Experiment Video
Updated: Aug 25, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Aspergillus infection of implantable cardioverter-defibrillator
Rachel J Cook1, Thomas A Orszulak, Vuyisile T Nkomo
1Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.
Abstract:
The use of pacemakers and implantable cardioverter-defibrillators continues to increase for the management of cardiac dysrhythmias and, more recently, heart failure. Long-term complications associated with their use include infection, lead failure, and spurious shocks. Although the risk of infection with intracardiac devices is well known, the clinical presentation of this complication can be insidious, delayed in onset, and difficult to diagnose. We report a case of Aspergillus fumigatus infection of an implantable cardioverter-defibrillator with right-sided endocarditis in a 55-year-old man. The infection presented as persistent pulmonary infiltrates (due to recurrent septic pulmonary embolism) and anemia more than 2 years after implantation of the device. Clinicians should be aware of the variable manifestations resulting from infection of intracardiac devices.
Related Concept Videos
Endocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Endocarditis III: Medical Management
Cardiopulmonary Resuscitation III: AED Use
Endocarditis IV: Nursing Management

